• locale

  United States

• market

  STOCKS

• industry

  Biotechnology

• website

  helixbiomedix.com/

• ipo date

  Mar 25, 1999

Helix BioMedix is focused on drug development for the treatment of rare dermatological diseases, with a portfolio that includes a proprietary library of patented bioactive peptides.